Diabetes Clinical Trials

Showing 6421-6440 of 7,874 trials

Blood Pressure Outcomes With Liraglutide Therapy

NCT01755572

Purpose: The purpose of this study is to further study the mechanism by which liraglutide, a relatively new anti-hyperglycemic medication, might lower blood pressure in patients with Type 2 diabetes and high blood pressure.

Type 2 DiabetesSystolic Hypertension

Mount Sinai Hospital, Canada22 participantsStarted Jan 2013

Toronto, Ontario, Canada

COMPLETED

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

NCT00229658

This is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace. Health care providers and subjects selected for study participation are intended to be representative of those providers prescribing, and subjects receiving, SYMLIN therapy.

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

AstraZeneca1,297 participantsStarted Sep 2005

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Tucson, Arizona, United States +104 more locations

Blood Pressure Outcomes With Liraglutide Therapy

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Related Searches

TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes

Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial

EndoBarrier Versus Intragastric Balloon in Obese Diabetic Patients

Phase I Multiple-Ascending Dose (Japan)

OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277

Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.

Effect of Coadministration of Ume Paste (Prunus Mume) and Ginger Powder

Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes

Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects

Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus

Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)

Impact of ELKa, the Toolset for Food Exchanges Calculation on Metabolic Control in Pediatric Diabetic Patients.

Impact of Individualized Structured Information Provision to the Patients, on Diabetes Related Outcomes

Single Site, Single Subject, Treatment IND With Mannkind Corporation's Technosphere Inhalation System

Intensive Lifestyle Intervention for Type 2 Diabetics: The KP TLC Pilot

A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)

Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)